✦ LIBER ✦

Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study

✍ Scribed by Stephen I. Shibata; James H. Doroshow; Paul Frankel; Timothy W. Synold; Yun Yen; David R. Gandara; Heinz-Josef Lenz; Warren A. Chow; Lucille A. Leong; Dean Lim; Kim A. Margolin; Robert J. Morgan; George Somlo; Edward M. Newman

Publisher: Springer
Year: 2009
Tongue: English
Weight: 310 KB
Volume: 64
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-009-0977-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Feasibility of biweekly combination chem

Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX

✍ T. Mazard; M. Ychou; S. Thezenas; S. Poujol; F. Pinguet; A. Thirion; J. P. Bleus 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 197 KB

Oblimersen and α-interferon in metastati

Oblimersen and α-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium

✍ Kim Margolin; Timothy W. Synold; Primo Lara; Paul Frankel; Simon F. Lacey; David 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 277 KB

A phase I and pharmacokinetic study of o

A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study

✍ Joseph Chao; Timothy W. Synold; Robert J. Morgan; Charles Kunos; Jeff Longmate; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 259 KB

A phase 1 study of hepatic arterial infu

A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver

✍ Apostolia M. Tsimberidou; Siqing Fu; Chaan Ng; Jo Ann Lim; Sijin Wen; David Hong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB 👁 1 views

A phase I, first in man study of OSI-783

A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group

✍ G. Goss; L. L. Siu; I. Gauthier; E. X. Chen; A. M. Oza; R. Goel; J. Maroun; J. P 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 233 KB

Long-term efficacy and safety of zoledro

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors : A randomized, Phase III, double-blind, placebo-controlled trial

✍ Lee S. Rosen; David Gordon; N. Simon Tchekmedyian; Ronald Yanagihara; Vera Hirsh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views